Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Cosmos Health Inc COSM

Healthcare
Cosmos Health Inc. is a global healthcare company. The Company owns a portfolio of pharmaceutical and nutraceutical brands, including Sky Premium Life, Mediterranation, bio-bebe and C-Sept. Through its subsidiary, Cana Laboratories S.A., it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. It distributes a line of pharmaceuticals... see more

Recent & Breaking News (NDAQ:COSM)

Cosmos Health Provides a Summary Regarding Recent Share Activity and Reiterates its Belief and Commitment to the Financial Strength and the Growth and Profitability of the Company

Accesswire December 2, 2022

Cosmos Health Enters the Development Phase for CCX0722, an Innovative Product for Obesity and Weight Management

Accesswire November 29, 2022

Cosmos Health to Sell its Sky Premium Life Luxury Food Supplement Brand on Iberian Airlines' In-flight Magazine, Ronda.

Accesswire November 21, 2022

Cosmos Health Requests Appeal from the Nasdaq Stock Market

Accesswire November 17, 2022

Cosmos Health Reports Third Quarter 2022 Financial Results

Accesswire November 15, 2022

Cosmos Health Obtains Exclusive Rights to Market and Distribute Nickelodeon's SpongeBob and PAW Patrol Kids' Vitamins in Greece and Cyprus

Accesswire November 14, 2022

Cosmos Health and Smart for Life Execute Letter of Intent for Strategic Global Co-Venture

GlobeNewswire October 27, 2022

Cosmos Health Announces Pricing of $7.5 Million Upsized Public Offering

Accesswire October 18, 2022

Cosmos Health Enters into a Warrant Exchange Agreement, Replacing Structured Warrants with Plain-Vanilla Warrants

Accesswire October 4, 2022

Cosmos Health Enters into Letter of Intent for the Acquisition of ZipDoctor, Inc., a Telehealth Company, from American International Holdings Corp.

Accesswire September 28, 2022

Cosmos Health Signs an Agreement with Virax Biolabs to Distribute Monkeypox Virus Real-Time PCR Detections Kits in Europe

Accesswire September 22, 2022

Virax Biolabs Group Limited Announces Distribution Agreement to Market Monkeypox Virus Real-Time PCR Detection Kit with Cosmos Holdings Inc.

PR Newswire September 22, 2022

Cosmos Health to Launch Sky Premium Life Nutritional Supplement Products in Germany and Austria via Amazon and Ebay

Accesswire September 15, 2022

Cosmos Health Launches First Sky Premium Life Nutritional Supplement Products on Amazon in the United States

Accesswire August 25, 2022

Cosmos Health Reports 202.42 % Increase in Adjusted EBITDA and Positive Operating Income for the First Half of 2022

Accesswire August 22, 2022

Cosmos Holdings Announces Name Change to Cosmos Health, Reflecting Company's Evolution into an Innovative Global Healthcare Group, Driven by One Purpose: Improving People's Lives

Accesswire July 29, 2022

Cosmos Holdings Appoints Dr. Manfred Ziegler to its Advisory Board

Accesswire July 22, 2022

Cosmos Holdings Announces Agreement to Acquire Cana Laboratories, a Legacy European Pharmaceutical Company Established in 1928; Vertically Integrating its Manufacturing and R&D Capabilities and Expanding its Product Pipeline with New Brands

Accesswire July 20, 2022

Cosmos Holdings Subsidiary Granted Full Membership in PAGB, A UK-based Consumer Healthcare Association

Accesswire July 12, 2022

Cosmos Holdings Appoints Dr. Panagiotis Zoumpoulakis to its Advisory Board

Accesswire July 8, 2022